21 studies found for:    "desmoid tumor"
Show Display Options
Rank Status Study
21 Completed Imatinib Mesylate And Cyclophosphamide In Metronomic Administration: Dose Escalation Study Of Imatinib Mesylate
Condition: Cancer
Interventions: Drug: Imatinib mesylate, Cyclophosphamide (Dosing level 1 );   Drug: Imatinib mesylate, Cyclophosphamide (Dosing level 2);   Drug: Imatinib mesylate, Cyclophosphamide (Dosing level 3);   Procedure: Blood sampling

Show previous page of results Previous Page (1-20) Studies Shown (21-21) Next Page
Indicates status has not been verified in more than two years